Letter from the Editor #615: Qnexa FDA Advisory Panel Approval

When it comes to weight loss medications the FDA’s motto appears to be, “If at first you don’t get approval, try, try, again,” and it worked as an FDA advisory panel recommended the approval of Qnexa after two previous rejections (See this week’s Item #3). This might just open the door for more approvals of previously rejected medications like Contrave and Lorgess (See this week’s Item #4) as we begin to realize how bad the obesity epidemic has become and how many of these patients are developing diabetes.

Topics: From the dLife vault. dLife takes an in-depth look at how our national food supply affects obesity and diabetes, and how people with diabetes make smart choices today. Plus, great tips for everyday eating with diabetes. Sundays on CNBC at 7 PM ET, 6 PM CT, and 4 PM PT. Catch up on dLife.com.